# Darifenacin

NDC: 33342-277
Generic name: Darifenacin
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20170729

FDA application: ANDA207302

## Active ingredients

- DARIFENACIN HYDROBROMIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-277"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-277
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ae60119-e22c-4806-a5d8-db7c9e8984a2